ArticleCancers2023

Selected Serum Biomarkers (Leptin, Chromogranin A, CA19-9, CEA) in Patients with Pancreatic Neuroendocrine Neoplasm and Associations with Metabolic Syndrome.

Violetta Rosiek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.